First time generic approvals at the US FDA have declined for a fourth straight year, although the drop could simply be a product of timing and workflow.
In the waning months of the first iteration of the Generic Drugs User Fee Act, FDA announced that it approved...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?